Inflammatory Response and Thrombosis in Older Individuals

Seminars in Thrombosis and Hemostasis

Volumn 40, Issue 6, 2014, Pages 669-674

  Schlaudecker, Jeffrey ^a   Becker, Richard ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

chronic inflammation; frailty; thrombosis

Indexed keywords

CYTOKINE;

ADIPOSE TISSUE; AGING; ARTICLE; BODY MASS; CHRONIC DISEASE; DIET; ENVIRONMENTAL FACTOR; FIBRINOLYSIS; HEALTH STATUS; HUMAN; IMMOBILITY; INFLAMMATION; INNATE IMMUNITY; METABOLIC SYNDROME X; MULTICENTER STUDY (TOPIC); OBESITY; PHENOTYPE; PHYSICAL ACTIVITY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; SOCIAL STATUS; THROMBOPHILIA; THROMBOSIS; AGE; BLOOD; PATHOLOGY;

AGE FACTORS; CHRONIC DISEASE; HUMANS; INFLAMMATION; THROMBOSIS;

EID: 84928408729     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0034-1387882     Document Type: Article

References (52)

1. Gharacholou S. M., Becker R. C. Hemostasis and thrombosis in older adults. J Thromb Thrombolysis: 2009; 27 2 249 251
2. Pretorius E., Oberholzer H. M., van der Spuy W. J., Meiring J. H. Age-related changes in fibrin networks and platelets of individuals over 75: a scanning electron microscopy study showing thrombotic preparedness J Thromb Thrombolysis: 2010; 29 3 271 275
3. Olivieri F., Procopio A. D., Montgomery R. R. Effect of aging on microRNAs and regulation of pathogen recognition receptors. Curr Opin Immunol: 2014; 29C 29 37
4. Jenny N. S., French B., Arnold A. M., et al. Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars. J Gerontol A Biol Sci Med Sci: 2012; 67 9 970 976
5. Akbaraly T. N., Hamer M., Ferrie J. E., et al. Chronic inflammation as a determinant of future aging phenotypes. CMAJ: 2013; 185 16 E763 E770
6. Hubbard R. E., O'Mahony M. S., Savva G. M., Calver B. L., Woodhouse K. W. Inflammation and frailty measures in older people. J Cell Mol Med: 2009; 13 0B 3103 3109
7. Akbaraly T., Sabia S., Hagger-Johnson G., et al. Does overall diet in midlife predict future aging phenotypes? A cohort study. Am J Med: 2013; 126 5 411 419, e3
8. Kuczmarski M. F., Mason M. A., Allegro D., Zonderman A. B., Evans M. K. Diet quality is inversely associated with C-reactive protein levels in urban, low-income African-American and white adults. J Acad Nutr Diet: 2013; 113 12 1620 1631
9. Deverts D. J., Cohen S., Kalra P., Matthews K. A. The prospective association of socioeconomic status with C-reactive protein levels in the CARDIA study. Brain Behav Immun: 2012; 26 7 1128 1135
10. Schafer M. H., Ferraro K. F., Williams S. R. Low socioeconomic status and body mass index as risk factors for inflammation in older adults: conjoint influence on C-reactive protein? J Gerontol A Biol Sci Med Sci: 2011; 66 6 667 673
11. Hamer M., Sabia S., Batty G. D., et al. Physical activity and inflammatory markers over 10 years: follow-up in men and women from the Whitehall II cohort study. Circulation: 2012; 126 8 928 933
12. Tiainen K., Hurme M., Hervonen A., Luukkaala T., Jylhä M. Inflammatory markers and physical performance among nonagenarians. J Gerontol A Biol Sci Med Sci: 2010; 65 6 658 663
13. Exploring the biological contributions to human health: does sex matter? J Womens Health Gend Based Med: 2001; 10 5 433 439
14. Yang Y., Kozloski M. Sex differences in age trajectories of physiological dysregulation: inflammation, metabolic syndrome, and allostatic load. J Gerontol A Biol Sci Med Sci: 2011; 66 5 493 500
15. Tofler G. H., Massaro J., Levy D., et al. Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study). Am J Cardiol: 2005; 96 9 1280 1283
16. Cohen H. J., Harris T., Pieper C. F. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med: 2003; 114 3 180 187
17. Walston J., McBurnie M. A., Newman A., et al. Cardiovascular Health Study Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med: 2002; 162 20 2333 2341
18. Franchini M. Hemostasis and aging. Crit Rev Oncol Hematol: 2006; 60 2 144 151
19. Leng S. X., Cappola A. R., Andersen R. E., et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res: 2004; 16 2 153 157
20. Wilkerson W. R., Sane D. C. Aging and thrombosis. Semin Thromb Hemost: 2002; 28 6 555 568
21. Yamamoto K., Takeshita K., Kojima T., Takamatsu J., Saito H. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovasc Res: 2005; 66 2 276 285
22. Bonfigli A. R., Sirolla C., Cenerelli S., et al. Plasminogen activator inhibitor-1 plasma level increases with age in subjects with the 4G allele at position -675 in the promoter region. Thromb Haemost: 2004; 92 5 1164 1165
23. Hamsten A., de Faire U., Walldius G., et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet: 1987; 2 8549 3 9
24. Wilson J. F. Frailty-and its dangerous effects-might be preventable. Ann Intern Med: 2004; 141 6 489 492
25. Hamsten A., Wiman B., de Faire U., Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med: 1985; 313 25 1557 1563
26. Yost C. C., Cody M. J., Harris E. S., et al. Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood: 2009; 113 25 6419 6427
27. Kotronen A., Joutsi-Korhonen L., Sevastianova K., et al. Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease. Liver Int: 2011; 31 2 176 183
28. Willenberg T., Schumacher A., Amann-Vesti B., et al. Impact of obesity on venous hemodynamics of the lower limbs. J Vasc Surg: 2010; 52 3 664 668
29. Cushman M., Callas P. W., Denenberg J. O., Bovill E. G., Criqui M. H. Risk factors for peripheral venous disease resemble those for venous thrombosis: the San Diego Population Study. J Thromb Haemost: 2010; 8 8 1730 1735
30. Severinsen M. T., Overvad K., Johnsen S. P., et al. Genetic susceptibility, smoking, obesity and risk of venous thromboembolism. Br J Haematol: 2010; 149 2 273 279
31. Goldhaber S. Z., Grodstein F., Stampfer M. J., et al. A prospective study of risk factors for pulmonary embolism in women. JAMA: 1997; 277 8 642 645
32. Blaszyk H., Wollan P. C., Witkiewicz A. K., Björnsson J. Death from pulmonary thromboembolism in severe obesity: lack of association with established genetic and clinical risk factors. Virchows Arch: 1999; 434 6 529 532
33. Stein P. D., Beemath A., Olson R. E. Obesity as a risk factor in venous thromboembolism. Am J Med: 2005; 118 9 978 980
34. Poirier P., Giles T. D., Bray G. A., et al. American Heart Association Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation: 2006; 113 6 898 918
35. Grignani G., Maiolo A. Cytokines and hemostasis. Haematologica: 2000; 85 9 967 972
36. Suganami T., Nishida J., Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol: 2005; 25 10 2062 2068
37. Engström G., Hedblad B., Stavenow L., et al. Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study. Arterioscler Thromb Vasc Biol: 2004; 24 8 1498 1502
38. Schernthaner G. H., Kopp H. P., Krzyzanowska K., Kriwanek S., Koppensteiner R., Schernthaner G. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery. Eur J Clin Invest: 2006; 36 6 395 401
39. Goichot B., Grunebaum L., Desprez D., et al. Circulating procoagulant microparticles in obesity. Diabetes Metab: 2006; 32 1 82 85
40. Smith N. L., Rice K. M., Bovill E. G., et al. Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. Blood: 2011; 117 22 6007 6011
41. den Hoed M., Ekelund U., Brage S., et al. Genetic susceptibility to obesity and related traits in childhood and adolescence: influence of loci identified by genome-wide association studies. Diabetes: 2010; 59 11 2980 2988
42. Freedman J. E., Larson M. G., Tanriverdi K., et al. Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study. Circulation: 2010; 122 2 119 129
43. Ford E. S., Giles W. H., Dietz W. H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA: 2002; 287 3 356 359
44. Beavers K. M., Hsu F. C., Houston D. K., et al. Health ABC Study The role of metabolic syndrome, adiposity, and inflammation in physical performance in the Health ABC Study. J Gerontol A Biol Sci Med Sci: 2013; 68 5 617 623
45. Kizer J. R., Arnold A. M., Jenny N. S., et al. Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study. J Gerontol A Biol Sci Med Sci: 2011; 66 10 1100 1107
46. Fain J. N., Madan A. K., Hiler M. L., Cheema P., Bahouth S. W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology: 2004; 145 5 2273 2282
47. Ferrucci L., Corsi A., Lauretani F., et al. The origins of age-related proinflammatory state. Blood: 2005; 105 6 2294 2299
48. Brinkley T. E., Hsu F. C., Beavers K. M., et al. Total and abdominal adiposity are associated with inflammation in older adults using a factor analysis approach. J Gerontol A Biol Sci Med Sci: 2012; 67 10 1099 1106
49. Cesari M., Kritchevsky S. B., Baumgartner R. N., et al. Sarcopenia, obesity, and inflammation-results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. Am J Clin Nutr: 2005; 82 2 428 434
50. Engbers M. J., Blom J. W., Cushman M., Rosendaal F. R., van Hylckama Vlieg A. The contribution of immobility risk factors to the incidence of venous thrombosis in an older population. J Thromb Haemost: 2014; 12 3 290 296
51. Dalager-Pedersen M., Sogaard M., Schonheyder H. C., Nielsen H., Thomsen R. W. M P-D Risk for myocardial infarction and stroke after community-acquired bacteremia: a 20-year population-based cohort study. Circulation: 2014; 129 13 1387 1396
52. Connolly-Andersen A. M., Hammargren E., Whitaker H., et al. Increased risk of acute myocardial infarction and stroke during hemorrhagic fever with renal syndrome: a self-controlled case series study. Circulation: 2014; 129 12 1295 1302